Further, in the rescue experiment, CASP2 overexpression rescued the effect of miR-494 on cisplatin-treated A549 cells, indicating that miR-494 reduces NSCLC cells’ sensitivity to cisplatin-induced apoptosis by targeting CASP2. This evidence concerns the gene CASP2 and non-small cell lung carcinoma.